We have reported that the active form of vitamin D3, 1 alpha,25-dihydroxyvitamin D3 [1 alpha,25(OH)2D3], directly induces activation and fusion of mouse alveolar macrophages (Abe et al., 1983, 1984). The activated state appeared to be a prerequisite to the fusion of macrophages. Macrophages began to fuse 36 hr after adding 1 alpha,25(OH)2D3; the fusion rate attained a maximum of 70-80% at 72 hr. During the course of further investigating the mechanisms of fusion induced by the vitamin, we found that the calcium ion is closely involved in the fusion process of macrophages induced by 1 alpha,25(OH)2D3. When alveolar macrophages were cultured with 1 alpha,25(OH)2D3 in medium with graded concentrations (0.13-1.85 mM) of calcium, the fusion rate went down in parallel with the decrease of medium calcium. Neither calcium ionophore A23187 nor 12-O-tetradecanoylphorbol-13-acetate (TPA) induced fusion of freshly isolated macrophages, but the two compounds greatly promoted fusion of the macrophages pretreated for 18 hr with 1 alpha,25(OH)2D3. The vitamin effect for the first 18 hr was similar, irrespective of the medium calcium concentration. In contrast, millimolar amounts of calcium were essential in the subsequent period of incubation(18-72 hr) for inducing fusion. The activation of macrophages measured by the induction of cytotoxicity and the enhancement of glucose consumption by 1 alpha,25(OH)2D3 occurred similarly, irrespective of the medium calcium concentration. These results clearly indicate that the fusion process of alveolar macrophages induced by 1 alpha,25(OH)2D3 can be divided into two phases: 1) the calcium-independent priming phase (0-18 hr) and 2) the calcium-dependent progression phase (18-72 hr). 1 alpha,25(OH)2D3 is necessary only in the priming phase; A23187 and TPA can be substituted for 1 alpha,25(OH)2D3 in the progression phase.